Ataxias esporádicas de início no adulto: um desafio diagnóstico by Barsottini, Orlando Graziani Povoas et al.
Adult onset sporadic ataxias: a diagnostic
challenge
Ataxias esporádicas de início no adulto: um desafio diagnóstico
Orlando Graziani Povoas Barsottini1, Marcus Vinicius Cristino de Albuquerque1, Pedro Braga-Neto1,2,
José Luiz Pedroso1
ABSTRACT
Patients with adult onset non-familial progressive ataxia are classified in sporadic ataxia group. There are several disease categories that
may manifest with sporadic ataxia: toxic causes, immune-mediated ataxias, vitamin deficiency, infectious diseases, degenerative disorders
and even genetic conditions. Considering heterogeneity in the clinical spectrum of sporadic ataxias, the correct diagnosis remains a clinical
challenge. In this review, the different disease categories that lead to sporadic ataxia with adult onset are discussed with special emphasis
on their clinical and neuroimaging features, and diagnostic criteria.
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RESUMO
Pacientes com ataxia progressiva que se inicia na idade adulta, e sem histórico familiar da doença, são classificados no grupo das ataxias
esporádicas. Existem várias categorias de doenças que podem se manifestar com ataxia esporádica, tais como: causas tóxicas, ataxias
imunomediadas, deficiência de vitaminas, doenças infecciosas, doenças degenerativas e até mesmo condições genéticas. Considerando a
heterogeneidade no espectro clínico das ataxias esporádicas, a definição da etiologia constitui um desafio diagnóstico. Neste artigo de
revisão, realizamos uma discussão sobre as diferentes categorias de doenças que causam ataxia com início na idade adulta sem histórico
familiar, com ênfase nas características clínicas, aspectos de imagem e critérios diagnósticos.
Palavras-chave: ataxia, ataxias esporádicas, aspectos clínicos, critérios diagnósticos.
The term ataxia traditionally means loss of order, and
clinically denotes loss of balance and coordination. On the
other hand, the name sporadic means without spot or regu-
lar pattern. Based on that, sporadic ataxia is defined as a
neurological condition characterized by ataxia of adult
onset, usually over 40 years old, with family history negative
for ataxia or its related symptoms and signs1.
The terminology ‘cerebellar ataxias’ comprises a wide
spectrum of neurological disorders with ataxia as the main
symptom. Ataxia results from the involvement of cerebellar
structures, or from a combination of cerebellar and extra-
cerebellar lesions, especially the brainstem2. Also, ataxias
are a heterogeneous group of diseases comprising genetic
and non-genetic etiologies. According to current etiology-
based classifications, the ataxias can be subdivided into six
major groups: autosomal dominant spinocerebellar ataxias
(SCA), autosomal recessive ataxias, congenital ataxias, mito-
chondrial ataxias, X-linked cerebellar ataxias and sporadic
ataxias1-3. A familial disorder affecting successive generations
is suggestive of SCA, while in patients with an early disease
onset, particularly before 25-year-old, an autosomal recessive
inheritance is most likely2,3. However, patients with adult
onset non-familial progressive ataxia are classified in spora-
dic ataxia group. There are several disease categories that
may manifest with adult onset sporadic ataxia and owing
to their heterogeneity, the correct diagnosis remains a clin-
ical challenge4.
In this review, the different disease categories that lead to
sporadic ataxia with adult onset are discussed with special
emphasis on their clinical features and diagnostic criteria.
Purposely, stroke and demyelinating diseases causing ataxia
were excluded from this review.
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ALCOHOLIC CEREBELLAR DEGENERATION
Alcoholic cerebellar degeneration is the most common
form of acquired toxic ataxia and is a frequent neurological
complication in alcoholics. Cerebellar symptoms usually
begin in middle-aged, and there is a marked history of
chronic alcohol abuse. Ataxia usually evolves rapidly, within
weeks to months, but some patients have a slower progres-
sion5. Neurological features comprise severe ataxia of gait
and lower limbs with relatively mild involvement of the
upper limbs. Interestingly, speech, ocular motility and coor-
dination extremities are usually preserved. Also, signs of
neuropathy, such as reduced or absent deep tendon reflexes,
are frequent1,5.
Neuroimaging features in alcoholic cerebellar degenera-
tion typically demonstrate cerebellar atrophy, in general with
preferential involvement of the superior cerebellar vermis
(Figure 1). Data from a clinicopathological study showed
that cerebellar atrophy and degenerative process in alcoholic
cerebellar degeneration begins in the superior vermis, and
cerebellar hemispheres are less involved5,6. Curiously,
another study showed that approximately 50% of the
chronic alcohol users have cerebellar atrophy without ataxia.
Symptomatic patients frequently have neuropsychological
impairment and variable degrees of brain atrophy5,6.
The pathogenesis of alcoholic cerebellar degeneration
includes both: the direct toxic effect of the alcohol to the
cerebellum and the consequences of vitamin B1 (thiamine)
deficiency. Alcohol produces a toxic effect to Purkinje cells,
and also is responsible for inhibitory mechanisms in GABA
system, increases lipid peroxidation, and reduces of antioxi-
dant concentrations7-9. Alcoholics have thiamine deficiency
as a result of poor diet, gastrointestinal disorders and liver
disease1. Treatment of alcoholic cerebellar degeneration
includes alcohol abstinence and thiamine replacement.
Variable degrees of clinical response may occur with treat-
ment: some patients have significant improvement of the
ataxia; others have only stabilization of symptoms; while a
smaller group may present slow progressive gait ataxia des-
pite alcohol discontinuation1.
ATAXIA RELATED TO TOXIC CAUSES
Besides alcohol, other substances abuse or exposure may
also cause or exacerbate the already pre-existing ataxia. The
main substances causing toxic ataxia are: lithium, phenytoin,
amiodarone, toluene and some chemotherapy’s (5-fluorour-
acil and cytosine arabinoside)10-14. There are also descrip-
tions of ataxia induced by mercury or bismuth
subsalicylate exposure15,16. Other drugs may rarely cause
cerebellar symptoms: carbamazepin, valproic acid, cyclos-
porine, isoniazid, metronidazole, nitrofurantoin, procaina-
mide and statins17,18. When toxic ataxia is suspected, these
substances should be immediately discontinued. Clinical
outcome is variable after drug cessation: patients may have
significant improvement or only stabilization of symptoms
with permanent cerebellar atrophy18.
PARANEOPLASTIC CEREBELLAR DEGENERATION
Paraneoplastic cerebellar degeneration is an immune-
mediated disorder that affects cerebellar cortex, usually
Figure 1. Brain MRI of a patient with alcoholic cerebellar degeneration (ACD). Sagittal T1-weighted brain MRI disclosed marked
cerebellar atrophy restricted to the superior vermis (A). Axial T1-weighted MRI of the same patient confirming atrophy in the
suoerior vermis (B). Axial FLAIR-weighted MRI: note that no atrophy in the medium or inferior vermis is observed (C). Neuroimaging
features in ACD typically demonstrate cerebellar atrophy restricted to the superior cerebellar vermis.
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associated with the following neoplastic diseases: small cell
lung cancer, breast cancer, ovarian cancer and Hodgkin’s
lymphoma19,20. In paraneoplastic cerebellar degeneration
the onset of gait ataxia is usually subacute, and symptoms
usually develop in few weeks, with rapid progression21.
Some authors subdivide paraneoplastic cerebellar degen-
eration into four groups: 1- cerebellar ataxia associated with
signs of a widespread involvement of the nervous system
(encephalomyelitis): seizures, behavior changes, memory
dysfunction, chorea, limbic encephalitis and peripheral
neuropathy. This phenotype is usually related to high serum
levels of anti-Hu and lung cancer; 2- pure cerebellar ataxia in
women, associated with high serum levels of anti-Yo and
gynecological tumors (breast or ovarian cancer); 3- pure
cerebellar syndrome, more commonly observed in men,
associated with Hodgkin’s lymphoma and high serum levels
of anti-Tr and mGluR1; 4- cerebellar ataxia associated with
Lambert-Eaton syndrome related to high serum levels of
anti-VGCC and lung cancer18,21,23.
Brain imaging may be frustrating, since initial magnetic
resonance imaging (MRI) is usually unremarkable. Signal
changes, particularly in superior vermis, may be found in
the beginning of symptoms24. Cerebellar atrophy frequently
develops in late stages. Cerebrospinal fluid (CSF) usually
shows mild pleocytosis or high levels of proteins25. Patients
should be promptly screened for anti-neuronal antibodies,
as described above. Search for the primary tumor is extre-
mely relevant in this syndrome.
In general, patients with paraneoplastic cerebellar degen-
eration do not respond to treatment of the underlying
tumor. Further, exceptional reports have demonstrated
improvement of the ataxia symptoms after immunotherapy
(intravenous human immunoglobulin, plasma exchange
or steroids)26.
IMMUNE-MEDIATED ATAXIAS
The cerebellum, in special the Purkinje cells, has an
important immunological target in the context of some sys-
temic diseases. Therefore, immune-mediated ataxias are
neurological conditions related to auto-immune disorders.
Immune-mediated ataxias include: gluten ataxia, ataxia
associated with antibodies against the glutamic acid decar-
boxylase (anti-GAD), steroid-responsive encephalopathy
associated with autoimmune thyroiditis and paraneoplastic
cerebellar degeneration (described in the item above)27.
Anti-GAD ataxia
High levels of glutamic acid decarboxylase (GAD) autoan-
tibody may be observed in a few patients with sporadic
ataxias, supporting autoimmune pathogenesis of the cere-
bellar syndrome. The clinical spectrum of anti-GAD ataxia
comprises slowly progressive cerebellar ataxia evolving in
months or years, associated with cerebellar atrophy on brain
MRI in about half of cases. Cerebrospinal fluid analysis may
detect oligoclonal bands. Diagnosis is supported by high
serum levels of GAD antibodies. Association with late-onset
type 1 diabetes and other auto-immune disorders is may be
observed28. Immunotherapy might be useful in anti-GAD
ataxia, but this is still controversial29.
Gluten related ataxia
Celiac disease is a chronic immune-mediated intestinal
disease, characterized by inflammatory process and villous
atrophy in intestinal mucosa. The diagnosis of celiac disease
is based on typical lesions in intestinal biopsy, associated or
not with specific antibodies. Much controversy remains
about a real causal relationship between asymptomatic
celiac disease and sporadic ataxia. Several data have demon-
strated a strong association between cerebellar ataxia and
silent coeliac disease, defined by the presence of antigliadin
antibodies and tissue transglutaminase levels30. Researchers
suggest that ataxia in patients with high serum levels of anti-
gliadin and transglutaminase antibodies are immune-
mediated and proposed the term “gluten ataxia".
Antibodies against transglutaminase 6 (TG6) are gluten-
dependent and appear to be a sensitive and specific marker
of gluten ataxia. Of note, up to 12% of the healthy population
may have high serum levels of antigliadin antibodies30,31.
Steroid-responsive encephalopathy associated
with autoimmune thyroiditis
Steroid-responsive encephalopathy associated with auto-
immune thyroiditis (SREAT), also known Hashimoto ence-
phalopathy, is an immune-mediated disease characterized
by subacute cognitive changes, cerebral ischemia, myo-
clonus, seizures, psychiatric symptoms, ataxia and high
serum levels of antithyroid antibodies (thyperoxidase or
thyroglobulin antibodies). Brain MRI may disclose mesial
temporal lobe lesions, multiple subcortical ischemic areas
or may be normal. CSF may show mild pleocytosis or high
levels of proteins. Interestingly, neurological deficits have
marked improvement after intravenous steroid therapy.
Response to steroids and the presence of antithyroid anti-
bodies, which are common markers of autoimmunity, sug-
gest that SREAT is an immune-mediated disorder32.
ACQUIRED ATAXIAS DUE TO VITAMIN DEFICIENCY
Vitamin B1 (Thiamine) deficiency
Vitamin B1 (thiamine) deficiency may cause ataxia in the
context of Wernicke encephalopathy (ataxia, confusion and
ophthalmoparesis), a condition more frequently observed
in alcoholics. Also, Vitamin B1 deficiency is presumed to
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be involved in the pathophysiology of alcoholic cerebellar
degeneration. Brain MRI may disclose symmetric signal
changes in thalami, mamillary bodies, tectal plate and peri-
aqueductal area33.
Vitamin B12 deficiency
Vitamin B12 deficiency occurs in the setting of atrophic
gastritis, pernicious anemia or disabsorptive syndromes.
Neurological features classically include sensory ataxia,
impaired deep sensitivity, peripheral neuropathy and pyr-
amidal signs. Serum levels of B12 are usually decreased,
but high levels of serum homocystein and methylmalonic
acid are also useful to suggest the diagnosis. In addition,
MRI may show high intensity signals in the posterior column
of cervical or thoracic spinal cord. Intramuscular replace-
ment of vitamin B12 should be promptly started34.
Vitamin E deficiency
Ataxia caused by vitamin E deficiency is an autosomal
recessive disorder, and generally has a childhood onset.
Rarely vitamin E deficiency causes ataxia in adulthood.
The clinical spectrum resembles Friedreich ataxia: progress-
ive ataxia, loss of proprioception, areflexia and Babinski
sign35. Brain MRI is usually normal, and cerebellar atrophy
is uncommon. Replacement with vitamin E usually improves
the symptoms36.
MULTIPLE SYSTEM ATROPHY - CEREBELLAR FORM
Multiple system atrophy (MSA) is an adult onset sporadic
neurodegenerative disease whose clinical spectrum is com-
prised by parkinsonian features (MSA-P) or cerebellar signs
(MSA-C). In both, pyramidal signs are frequent and auto-
nomic dysfunction is mandatory. Autonomic dysfunction is
variable, and mostly related to urinary disturbances and pos-
tural hypotension. The estimated annual prevalence of the
disease is 0.6:100.000 per year, reaching 3:100.000 in popula-
tions over 50 years. Median survival is 8-10 years. The under-
lying neuropathological findings in MSA are the presence of
glial cytoplasmatic inclusions in oligodendroglial cells at aut-
opsy. Due to the abundant presence of alpha-synuclein in
this disease, similar to Parkinson’s disease and dementia
with Lewy bodies, MSA is currently classified as synucleino-
pathie. Patients with MSA present a widespread involvement
of the central nervous system, with degeneration including
basal ganglia, brainstem, cerebellum, pyramidal tracts and
spinal cord37.
Historically, the previous term olivopontocerebellar
atrophy, when associated with dysautonomia, is in fact the
so called MSA. In MSA-C, the clinical features are mainly
characterized by cerebellar ataxia, ocular motility abnormal-
ities and dysarthria. Eventually, patients with MSA-C are
difficult to be distinguished from other forms of adult-onset
ataxia. Autonomic dysfunction may be mild or absent in the
beginning of the ataxia symptoms, and appear in the course
of the disease progression. Response to levodopa is poor in
MSA-C37,38.
Typical neuroimaging features in MSA-C include hyper-
intense signal in cerebellar peduncles, olivopontocerebellar
atrophy (cerebellum and brainstem), and "hot cross bun"
sign, which indicates degeneration of the pons fibers
(Figure 2)1,37.
IDIOPATHIC LATE-ONSET CEREBELLAR ATAXIA
Several patients present with slow progressive pure cere-
bellar ataxia syndrome in adulthood, or sometimes in elderly,
with no remarkable family history. Complementary invest-
igation for sporadic ataxias is frequently inconclusive. In
general, this group of patients has a degeneration restricted
to the cerebellum, sparing the brainstem. This neurological
condition is better known as idiopathic late-onset cerebellar
ataxia (ILOCA)39,40. Substantial phenotype variability exists in
ILOCA, which suggests that there are several still unknown
genetic or degenerative causes. In opposite to MSA-C, brain
MRI discloses atrophy limited to the cerebellum. Notably,
disease progression is lower in ILOCA than in MSA-C, and
life expectancy is probably normal. Some patients are mista-
kenly diagnosed with ILOCA, but dysautonomia may appear
in the course of the disease, supporting the diagnosis of
MSA-C. The diagnosis of ILOCA may be carefully done, by
ruling out other acquired and genetic disease. To date, etiol-
ogy and pathophysiology of ILOCA remain unclear. It is
uncertain whether ILOCA is a homogeneous disease or a
group of phenotypically similar syndromes represented by
different neurodegenerative or genetic entities1,39,40.
ATAXIAS DUE TO INFECTIOUS DISEASES
Progressive adult onset sporadic ataxias may rarely be
caused by chronic infections of the central nervous system.
The most common infections related to progressive sporadic
ataxia are neurosyphilis, Whipple’s disease, Lyme disease
and HIV.
The classical example of progressive ataxia caused by
infection of the nervous system is neurosyphilis (bacterium
Treponema pallidum). In neurosyphilis, ataxia is purely sens-
ory associated with pain, bladder dysfunction, and abnormal
pupillary reflexes. Ataxia is due to the involvement of the
posterior horn of the spinal cord41.
Whipple’s disease is a systemic infection caused by
the bacterium Tropheryma whipplei. The classical clinical
manifestations of Whipple’s disease include fever, weight
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loss, diarrhea and arthritis, whereas the most com-
mon neurological manifestations are neuropsychiatric dis-
orders, cognitive impairment and ataxia. Diagnosis is
made through duodenal biopsy (PAS-positive, non-acid-fast
macrophage inclusions). Blood or CSF PCR analysis may
be confirmatory42.
Finally, progressive ataxia may rarely be observed in
HIV-infected patients, and cerebellar syndrome occurs
most commonly due to lesions of the cerebellum for oppor-
tunistic infections43.
PRION DISEASES
Human prion diseases are a group of rare neurodegenera-
tive disorders characterized by the conversion of the consti-
tutively expressed prion protein, PrP(C), into an abnormally
aggregated isoform, called PrP (Sc). There are four human
prion diseases: Creutzfeldt-Jakob disease, Gerstmann-
Straussler-Scheinker syndrome, fatal familial insomnia and
Kuru. Creutzfeldt-Jakob disease, the most common disease
of this group, is a rapidly progressive dementia with cortical
blindness, myoclonus and cerebellar ataxia. Up to 70% of
patients die within 6 months from first symptoms onset.
The electroencephalogram (pseudoperiodic sharp), raised
CSF 14-3-3 protein and neuron-specific enolase are helpful
findings44. Bilateral hyperintensity of the thalamic pulvinar
nucleus in T2, FLAIR and DW sequences (pulvinar sign) in
brain MRI is frequently related1. Gerstmann-Straussler-
Scheinker disease is a prionic disorder that causes ataxia
and dementia. It is almost always an autosomal dominant
inherited disorder and there are only few families described
around the world. Onset of the disease usually occurs
between the ages of 35 and 5544.
OTHER UNUSUAL SPORADIC ATAXIAS
Superficial siderosis
Superficial siderosis is a disorder characterized by free
iron hemosiderin (a product of the breakdown of blood)
deposition in the pial and subpial layer of the CNS. This
condition is characterized by a triad of symptoms comprised
by sensorineural hearing loss, cerebellar ataxia and pyr-
amidal signs45. Ataxia is frequently the predominant and
first symptom1,45. T2-weigheted brain MRI is pathogno-
monic, by demonstrating hypointense signal around the
brainstem, cerebellum and spinal cord (Figure 3). Among
reported cases of secondary superficial siderosis, current or
previous CNS tumors are the most common causes, followed
by head or spine trauma, and arteriovenous malformations/
aneurysms. However, in some cases, the source of bleeding
remains obscure, despite extensive imaging and angiogra-
phy. Once symptoms have appeared, the goal of therapy
consists in preventing progression by ablating the origin of
subarachnoid hemorrhage when correctly identified1,45.
Progressive ataxia and palatal tremor
Progressive ataxia and palatal tremor (PAPT) represents
a neurodegenerative disorder characterized by late-onset
progressive cerebellar ataxia, oculomotor disturbances and
symptomatic palatal tremor46. Typical neuroimaging fea-
tures include hypertrophy and hyperintense signal in the
olivary complexes, and cerebellar atrophy47. PAPT may be
Figure 2. Brain MRI of a patient with multiple system atrophy, cerebellar form (MSA-C). Axial T1-weighted sequence: note the “hot
cross bun" sign indicated by the arrow, with atrophy of the brainstem and cerebellum (A). Sagittal T1-weighted sequence: there is
clear olivopontocerebellar atrophy (cerebellum and brainstem involvement) (B).
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divided into sporadic and familial forms. The cause of spora-
dic PAPT remains uncertain46.
Histiocytosis of the nervous system
Histiocytosis, both Langerhans and non-Langerhans
cell type, may be associated with cerebellar white matter
changes48,49. The clinical spectrum is characterized by
ataxia and pyramidal signs, and, sometimes, by cogni-
tive dysfunction. Neuroimaging features include cerebellar
white matter changes, as well as brainstem and basal
ganglia abnormalities (Figure 4). Patients with cere-
bellar white matter abnormalities should be monitored
for histiocytosis48-50.
HEREDITARY ATAXIAS
Autosomal recessive ataxias
Although unusual, hereditary ataxias may eventually pre-
sent with sporadic adult onset. Late-onset Friedreich ataxia
(LOFA) has adult onset, particularly in patients with small
CAG expansions50-52. Approximately 15% of patients with
Friedreich ataxia have the beginning of symptoms over 25-
year-old. Interestingly, there are some reports of Friedreich
ataxia patients with onset of ataxia symptoms after 60-year-
of-old. Usually, patients with LOFA have pyramidal signs,
spasticity and brisk deep tendon reflexes, in opposite to
the classical phenotype of Friedreich ataxia51,52.
Figure 3. Brain MRI of a patient with superficial siderosis. Axial T2-weighted sequence: linear hypointense signal (arrow),
characterizing iron deposition on the surface of the brainstem and cerebellum (A). Sagittal T2-weighted sequence demonstrating
hypointense signal and iron deposition around the brainstem, and and spinal cord compression due to herniated posterior disc
(postoperative) (B).
Figure 4. This is a brain MRI of a patient with histiocytosis. Coronal T2-weighted brain MRI shows cerebellar white matter (dentate
nucleus) involvement (arrows) (A); Axial T2-weighted brain MRI discloses hyperintense lesions in middle cerebellar peduncles and
pons (arrows) (B).
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Table. This table lists the clinical spectrum, laboratory findings and neuroimaging features of the main causes of adult onset
sporadic ataxias.
Etiology Clinical spectrum Laboratory findings Neuroimaging features
Alcoholic
cerebellar
degeneration
Severe ataxia of gait and lower
limbs with relatively mild
involvement of the upper limbs;
Neuropathy
Unremarkable Cerebellar atrophy with preferential
involvement of the superior cerebellar vermis
Ataxia related
to toxic causes
Exposure or abuse of substances Elevated plasma levels of substances
like lithium, and phenytoin
Unremarkable; Cerebellar atrophy in late
stages
Paraneoplastic
cerebellar
degeneration
Subacute ataxia in weeks with
rapid progression
Elevated levels of Anti-HU, Anti-Yo,
Anti-Tr, Anti mGluR1 or anti-VGCC;
CSF with mild pleocytosis or high
levels of proteins
Signal changes, particularly in superior vermis;
Cerebellar atrophy in late stages.
Anti-GAD
ataxia
Slowly progressive cerebellar
ataxia evolving in months or years
High serum levels of GAD antibodies;
Oligoclonal bands on CSF
Cerebellar atrophy
Gluten related
ataxia
Slowly progressive cerebellar
ataxia evolving in months or years
Antigliadin antibodies and tissue
transglutaminase levels
Unremarkable. Cerebellar atrophy in late
stages
SREAT Subacute cognitive changes,
cerebral ischemia, myoclonus,
seizures, psychiatric symptoms
and ataxia
High serum levels of thyperoxidase
or thyroglobulin antibodies; CSF with
mild pleocytosis and high levels of
proteins
Mesial temporal lobe lesions, multiple
subcortical ischemic areas or may be normal.
Vitamin B1
(Thiamine)
deficiency
Ataxia, confusion and
ophthalmoparesis (Wernicke
encefalopathy); Alcoholic
cerebellar degeneration.
Low plasma levels of thiamine. Normal
vitamin B1 does not exclude the
disease.
Symmetric signal alterations in the thalami,
mamillary bodies, tectal plate and
periaqueductal area
Vitamin B12
deficiency
Sensory ataxia, impaired deep
sensitivity, peripheral neuropathy
and pyramidal signs
Anemia with elevated MCV; Low plasma
levels of vitamin B12 or high levels of
homocystein and methylmalonic acid
High intensity signals in the posterior
column of cervical or thoracic spinal cord
Vitamin E
deficiency
Progressive ataxia, loss of
proprioception and areflexia and
positive Babinski sign.
Reduced plasma levels of vitamin E Cerebellar atrophy is uncommon
MSA-C Cerebellar ataxia, ocular motility
abnormalities and dysarthria and
autonomic dysfunction
Unremarkable Hyperintense signal in cerebellar peduncles,
olivopontocerebellar atrophy and "hot cross
bun" sign
ILOCA Slow progressive pure cerebellar
ataxia syndrome in adulthood or
elderly
Unremarkable Atrophy limited to the cerebellum
Whipple’s
disease
Fever, weight loss, diarrhea,
arthritis, neuropsychiatric
symptoms, cognitive impairment
and ataxia
Blood or CSF PCR for Tropheryma
whipplei;
Unilateral or bilateral abnormal T2 signal
intensity most evident on FLAIR sequences
within the mesial temporal lobe, midbrain,
hypothalamus, and thalamus
Neurosyphilis
ataxia
Ataxia is purely sensory
associated with pain, bladder
dysfunction, and abnormal
pupillary reflexes
Positive serologic and CSF tests for
Syphilis
High intensity signals in the posterior column
of cervical or thoracic spinal cord
HIV Subacute ataxia which progress
in months
Positive serologic test for HIV Cerebellar atrophy
Creutzfeldt-
Jakob disease
Rapidly progressive dementia
with cortical blindness,
myoclonus and cerebellar ataxia
CSF 14-3-3 protein and neuron-specific
enolase
Bilateral hyperintensity of the thalamic pulvinar
nucleus in T2, FLAIR and DW sequences
(pulvinar sign); high signal abnormalities in
FLAIR and DW sequences in caudate nuclear
and putamen or cortical regions
Superficial
siderosis
Sensorineural hearing loss,
cerebellar ataxia and pyramidal
signs
Unremarkable Hypointense signal around the brainstem,
cerebellum and spinal cord
PAPT Late-onset progressive cerebellar
ataxia, oculomotor disturbances
and symptomatic palatal tremor
Unremarkable Hypertrophy and hyperintense signal in the
olivary complexes and cerebellar atrophy
Histiocytosis of
the nervous
system
Ataxia, pyramidal signs and
cognitive dysfunction
Unremarkable Cerebellar white matter changes, as well as
brainstem and basal ganglia abnormalities
LOFA Ataxia, pyramidal signs, spasticity
and brisk deep tendon reflexes
Positive genetic test for Friedreich
ataxia
Mild cerebellar atrophy in late stages
FXTAS Adult-onset ataxia associated
with tremor and mild cognitive
impairment
Positive genetic test for premutation of
Frangile X gene (CGG repeats between
55 and 200)
Hyperintense signal in the dentate nucleus
extending to the middle cerebellar peduncle
bilaterally, as well as global changes in
cerebral white matter
Adult-onset
Alexander
disease
Progressive pyramidal signs,
cerebellar ataxia, palatal tremor
and bulbar palsy.
GFAP gene mutation Spinal cord and medulla oblongata atrophy
CSF: cerebral spinal fluid; GAD: glutamic acid decarboxylase; SREAT: steroid-responsive encephalopathy associated with autoimmune thyroiditis; MCV:
mean corpuscular volume; MSA-C: multiple system atrophy - cerebellar form; ILOCA: idiopathic late-onset cerebellar ataxia; PAPT: progressive ataxia and
palatal tremor; LOFA: late-onset Friedreich ataxia; FXTAS: fragile-X-associated tremor/ataxia syndrome; GFAP: glial fibrillary acidic protein.
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Autosomal dominant spinocerebellar ataxias
The autosomal dominant spinocerebellar ataxias (SCAs)
should not be tested routinely in patients with sporadic
adult-onset ataxia. However, few reports have demonstrated
some SCAs with this presentation, particularly SCA6.
Presumed explanations for SCAs presenting with sporadic
adult onset ataxia include: de novo mutation, doubtful
paternity, and small CAG expansions1.
Fragile-X-associated tremor/ataxia syndrome
Another hereditary ataxia with late onset and sporadic
presentation is the Fragile-X-associated tremor/ataxia syn-
drome. This condition occurs in men (X-linked disease),
although rare reports have been described in women, by
mutation in the FMR1 gene and expansion of the trinucleo-
tide CGG repeats between 55 and 200, unlike the classic fragile
X syndrome, which occurs for expansion up to 200 repetitions.
The clinical spectrum of this syndrome includes adult-onset
ataxia associated with tremor and mild cognitive impair-
ment1,53. Brain imaging typically discloses hyperintense signal
in the dentate nucleus extending to the middle cerebellar ped-
uncle bilaterally, as well as global changes in cerebral white
matter. The diagnosis is confirmed when pre-mutation
between 55 and 200 repeats in the FMR1 gene is found53.
Adult-onset Alexander disease
Adult-onset Alexander disease is an underdiagnosed gen-
etic entity, clinically characterized by progressive pyramidal
signs, cerebellar ataxia, palatal tremor and bulbar palsy.
The disease is caused by glial fibrillary acidic protein
(GFAP) gene mutation. Spinal cord and medulla ablongata
atrophy are typical neuroimaging features54.
Mitochondrial and other genetic diseases
Mitochondrial diseases may present with adult onset
ataxia, and these cases are mainly related to mutation of
mitochondrial DNA polymerase c (POLG). Furthermore,
storage diseases, such as Niemann-Pick type C disease,
Tay-Sachs disease, Krabbe disease, and other forms of
recessive ataxias, such as ataxia with ocular apraxia and
ataxia-telangiectasia may rarely present with adult onset
ataxia2,36,55. Finally, sporadic ataxia may be the clinical pre-
sentation of new mutations recently described in autosomal
recessive ataxias with adult onset of symptoms, such as
SYNE1 mutations56.
FINAL REMARKS
To diagnosis the exact etiology of a adult onset sporadic
ataxia is a challenge. Careful attention to history, neuro-
logical examination and imaging features is crucial to guide
investigations and shorten the long list of diagnostic pos-
sibilities in a patient with sporadic and non-familiar adult-
onset ataxia. It is essential to target first on structural lesions
(e.g. tumors, stroke and multiple sclerosis) and treatable con-
ditions. Complementary, laboratorial and genetic investiga-
tion studies are generally excessively requested in patients
with sporadic ataxia. When initial laboratorial studies do
not yield a specific or obviously treatable condition in a
patient with progressive sporadic ataxia, the possibility of
a primary degenerative condition becomes more likely.
Table summarizes the clinical spectrum, laboratory findings
and neuroimaging features of the main causes of adult onset
sporadic ataxias.
Enormous progress in the discoveries for genetic and
molecular causes of ataxias has been made for the last
decades. Furthermore, definition of clinical criteria and
standard for imaging features has facilitated the correct dia-
gnosis of the numerous forms of sporadic ataxias. Despite so
many genetic discoveries, ease for imaging tests, and all
laboratory investigation described in this review, etiology
of sporadic ataxia remains a diagnostic challenging for the
general neurologist.
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